While most major centers are very familiar with these drugs now, you can always bring your prescription or the original packaging
Semaglutide, primarily used for type 2 diabetes treatment, has shown significant results in weight loss
Regular check-ups and open communication with your doctor are crucial for monitoring and managing these potential issues
If you notice changes to your period after starting any weight loss medication, it is worth discussing this with your GP or prescribing clinician, as it may indicate a need to review your treatment plan
In vitro experiments revealed that, under non-inflammatory conditions, NRF2 knockdown did not induce activation of the STAT3 or NF-B pathways, nor did it affect the expression of K16 and K17
It was MHRA-approved on 11 June 2026 but has not yet launched commercially